Learning Objectives:

  1. The learner will be able to describe donor derived cell-free DNA and its use in medicine, currently.
  2. The learner will be able to describe how donor derived cell-free DNA can be used to monitor for cellular and antibody mediated rejection.
  3. The learner will be able to describe how donor derived cell-free DNA as an aid to diagnose rejection.
Session date: 
Thursday, February 4, 2021 - 4:00pm to 5:00pm
Location: 
Zoom meeting
5700 S Maryland Ave
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Daniel C. Brennan, M.D., F.A.C.P.